Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Deals
Features
News
Region
Sectors
Size
Uncategorised

Exit

Arista arranges Big Switch acquisition
Big Switch Networks, based on Stanford research, had raised more than $120m from investors including Dell Technologies Capital, Intel Capital and Accton.
Revolution Medicines to rule with $100m IPO
Revolution Medicines, based on research from University of Illinois at Urbana-Champaign, Stanford University and UC Berkeley, has filed for a $100m initial public offering.
Apple expends $200m on Xnor.ai acquisition
The edge computing technology developer has reportedly been purchased by Apple, three years after being spun out of AI2 to advance work by University of Washington's Ali Farhadi.
Galecto gallops to PharmAkea merger
Galecto, based on research at Lund and Edinburgh universities, is merging with PharmAkea, with the joint entity retaining the Galecto name and leadership team.
Altair lands NewFasant
Altair has picked up computational electromagnetics software developer NewFasant, based on the research of University of Alcalá associate professor Lorena Lozano Plata.
Vicis veers into receivership
Football helmet producer Vicis, a University of Washington spinout, has succumbed to cash pressures despite previously raising $85m in funding.
Johnson & Johnson takes Taris in acquisition deal
MIT's Taris, which is developing a drug delivery system for bladder diseases, has been purchased by Johnson & Johnson.
DuPont absorbs UCD’s OxyMem
UCD-founded wasterwater purification spinout OxyMem has been bought by DowDuPont, already one of its shareholders.

Other News

EdtechX extrapolates Meten Education
Tsinghua University-backed Meten Education will merge with EdtechX to pursue market share with Chinese students and young professionals.
Spectral Edge puts Apple in the picture
Apple has picked up UEA's camera enhancement spinout Spectral Edge in a deal expected to boost the photography capabilities of its smartphones.
Waymo clears space for Oxford's Latent Logic
Alphabet’s Waymo has bought Latent Logic, which has developed imitation learning-powered simulators to train autonomous vehicles.
Streem nudges open Frontdoor
Rogue Venture Partners-backed Streem has been bought by Frontdoor, which has plans for its augmented reality-based remote home services technology.
Crystal Amber strikes at Allied Minds
Allied Minds' co-CEOs and chairman are under pressure from activist investor Crystal Amber despite having only taking their posts in June 2019.
Acticor conjures up $24.7m series B
The Inserm spinout secured a $7.8m series B extension and boosted its portfolio with the acquisition of AVCare, a Satt Ouest Valorisation-allied business.

Editor's Picks

Otsuka takes up Veryan’s acquisition offer
ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.
Big deal: Orchard harvests $200m IPO
Orchard Therapeutics has listed in the US following a $200m initial public offering that came just three years after the gene therapy developer was spun out of UCL.
Big deal: Novo pens $800m Ziylo acquisition
Ziylo, a spinout from University of Bristol that is working on a diabetes treatment, has been acquired by Novo Nordisk for a total that could exceed $800m.
Big deal: Nucana and Nightstar race to public markets
Nucana, a Scottish Investment Bank-backed cancer treatment developer, and Nightstar Therapeutics, an Oxford spinout focused on retinal gene therapies, have entered the public market.
test reg

Login